The race for a Lyme disease vaccine

Scientists and pharmaceutical companies are racing to develop a human vaccine for Lyme disease, but increasing vaccine skepticism more broadly has some advocates concerned that politics will stand in the way of new Lyme vaccines advancing.

Lyme disease, the most common vector-borne disease in the United States, is not life-threatening and is treatable if detected early, but it can have devastating neurological and autoimmune consequences long term, including chronic pain, arthritis, and severe headaches.